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IMPORTANCE The improved knowledge of clinical, morphologic, and epidemiologic
heterogeneity of melanoma in the context of multiple primary and familial melanomasmay
improve prevention, diagnosis, and prognosis of melanoma.
OBJECTIVE To characterize reflectance confocal microscopy (RCM)morphologic patterns of
melanomas in multiple primary and familial melanomas.
DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional, retrospective study, patients in a
hospital-based referral center were recruited fromMarch 1, 2010, through August 31, 2013;
data analysis was conducted from September 1, 2013, throughMay 31, 2014. Consecutive
primary melanomas, documented by dermoscopic and confocal examination, frommultiple
primary and familial melanomas with known CDKN2Amutational status were studied.
MAIN OUTCOMES ANDMEASURES Epidemiologic, genetic, dermoscopic, and histologic data
were evaluated according to an RCMmorphologic classification: dendritic cell, round cell,
dermal nest, combined, and nonclassifiable types.
RESULTS Fifty-sevenmelanomas from 50 patients (28 women [56%] and 49white patients
[98%]) were included: 23 dendritic cell (40%), 21 round cell (37%), 2 dermal nests (4%),
2 combined (4%), and 9 nonclassifiable (16%). Themedian (SD) age of the participants was
53.0 (16.9) years (interquartile range, 41.8-71.2 years), and themedian (SD) age at the first
melanomawas 46.0 (17.1) years (interquartile range, 35.8-61.5 years). Dendritic cell
melanomawas characterized by older age at diagnosis, phototypes 2 and 3, more intense
solar exposure, andmoderate to severe solar lentigines; it was themost prevalent confocal
type in facial lesions and was associated with the lentigo maligna histologic subtype. Round
cell melanomas were identified more often in the familial context and in individuals with
phototype 1 skin types; RCM features, such as junctional thickening, dense dermal nests, and
nucleated cells within papillary dermis, were more frequently found in this subtype. Dermal
nest and combinedmelanomawere associated with the absence of pigmented network on
dermoscopy and thicker tumors on histologic analysis. Nonclassifiable type was associated,
by RCM, with the absence of pagetoid cells on confocal examination and lower frequency of
marked atypia onmelanocytes in the basal cell layer; it presented with lower ABCD Total
Dermoscopy Scores and RCM scores compared with the other types. CDKN2Amutation
carriers may develop any RCM type of melanoma.
CONCLUSIONS AND RELEVANCE Different routes to developmelanoma can be identified
according to RCMmorphologic classification, with dendritic cell melanomas being associated
with chronic sun damage and round cell melanomawith early age at onset and phototype 1 in
the context of multiple primary and familial melanomas. Themorphologic expression of
melanomas via dermoscopy and confocal examination varies according to differences in
tumor stage and biological behavior.
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C urrently, morphologic analysis–basedmelanoma clas-sification is insufficient to provide enough informa-tionabout causative factorsor to selectpatients for spe-
cific treatments.1 In fact, refining classification ofmelanomas
into morphologic subtypes that correlate with phenotypical
characteristics or prognostic factorsmay enhance knowledge
about the disease and create a model for future investiga-
tions with molecular analysis and/or therapy stratification.
In vivo reflectance confocal microscopy (RCM) is a non-
invasive imaging technique that allows for the en face visual-
izationofmicroscopic structures and cellular detail in the epi-
dermis andsuperficial dermis athistopathologic resolution.2,3
Furthermore, integrating dermoscopy and confocal tech-
niques is useful for distinguishing early-stagemelanoma that
lacks frankly malignant features, especially in high-risk pa-
tients during follow-up,4,5 adding to morphologic informa-
tion about the biology of the lesions. The use of in vivo RCM
added anewdimension inmelanomaknowledge because the
entire surface of the melanoma can be analyzed at histologic
resolution. Not only the tumor but also patient characteris-
ticsmay influence themorphologic findings. In fact,CDKN2A
germline mutations and genetic variants inMC1Rmay influ-
encedermoscopic features.AmongSpanishcarriersofCDKN2A
mutations, the presence of 2MC1R red hair color variantswas
associatedwithmelanomaswith a less suspicious clinical and
dermoscopic appearance.2,6-10 Recently, 4 distinct mela-
noma phenotypes on RCM were described as follows: den-
dritic cell, roundcell, dermalnest, andcombinedmelanomas.11
Theauthors found thatmelanomaswithapredominantpopu-
lation of dendritic cells were thinner by Breslow index, and
melanomas typifiedby roundishmelanocytes ordermalnests
were smaller but thicker by Breslow index.11 The purpose of
this study was to correlate morphologic RCM patterns with
clinical data, genetic variants, dermoscopic features, and
histologic criteria in the context of patients with multiple
primary and familial melanomas.
Methods
Patient andMelanoma Selection
A cross-sectional, retrospective, hospital-based study was
performed that included patients treated and followed up at
the Melanoma Unit of the Hospital Clinic, Barcelona, Spain,
fromMarch 1, 2010, throughAugust 31, 2013;dataanalysiswas
conducted from September 1, 2013, through May 31, 2014.
The inclusion criteria were patients undergoing periodic
follow-upat theMelanomaUnitwithahistoryofat least2mela-
nomas (multiple primary melanoma) or hereditary familial
melanoma (≥2 patients affected by melanoma in first- or
second-degree relatives or at least 1 primarymelanomaandat
least 1 first- or second-degree relative with pancreatic can-
cer). Primary melanomas proven by histopathologic exami-
nation (any histologic subtype, Breslow Index ≤3 mm) and
documented by photographic dermoscopic and confocal ex-
amination and known CDKN2A status (wild type ormutated)
were included. Tumors thicker than 3 mm were excluded to
avoid outliers that couldmodify the interpretation of results.
Because this study is focused on morphologic classification
based on confocal microscopy of primary melanomas, we
wanted toavoid themoreadvanced tumorsbecause losingpri-
mary morphologic features and acquiring more heteroge-
neity could obscure the results of our study. Patientswith ge-
netic conditions, such as Li-Fraumeni syndrome, xeroderma
pigmentosum, and albinism, and patients undergoing sys-
temic treatment for advanced melanoma were excluded.
Clinical data were collected for each patient, and tumor
characteristics were also registered.
The study was approved by the ethical committee of
Hospital Clinic of Barcelona. Written informed consent was
obtained from each patient, and data were deidentified.
Dermoscopic Analysis
Dermoscopic images were captured using digital cameras
(OlympusCamedia [OlympusAmerica Inc], CanonG7 [Canon
Inc], and/orNikonCoolpix 4500 [NikonCorp]) equippedwith
apolarizeddermatoscope(DermlitePhoto;3GENLLC)andwith
a epiluminescence microscope system (Mole Max II; Derma
Medical Systems). Dermoscopic evaluation was based on the
pattern analysis and ABCD Total Dermoscopy Score (TDS) as
follows: (A) asymmetry, (B) borders, (C) colors, and (D) differ-
ent structural components (structureless areas, pigment net-
work,branchedstreaks,dots, andglobules).12,13ATDS less than
4.75 is indicative of a benignmelanocytic lesion, a TDSof 4.75
through5.45 is suggestivebutnotdiagnosticofmelanoma,and
a TDS greater than 5.45 should be considered melanoma.
Confocal Analysis
ConfocalexaminationswereperformedbyVivascope1500(Lucid
Inc).Distinctmelanoma typesbasedonRCMwere classifiedas
recentlyproposedbyPellacani et al11: (1) dendritic cellmelano-
mas, with a predominantly dendritic cell population and rings
and/or thinmeshworkpattern; (2) roundcellmelanomas,with
predominantly large,roundishcellswithatendencytoaggregate
intonests formingameshworkpattern; (3)dermalnestmelano-
mas,with predominantly large aggregates of cells in the papil-
larydermis; (4)combinedmelanomas,withacombinationofthe
3previousconfocalpatterns;and(5)nonclassifiablemelanoma,
without any of the previous patterns.
Key Points
Question Is reflectance confocal microscopy a reliable tool to
classify melanomas into subtypes and correlate themwith
phenotypic and genetic background?
Findings This cross-sectional, retrospective study evaluated 57
melanomas from high-risk patients. Dendritic cell melanomawas
characterized by older age at diagnosis, phototypes 2 and 3, more
intense solar exposure, and solar lentigines; round cell melanomas
were identified more often in familial context and in individuals
with phototype 1 skin type; and patients with CDKN2Amutational
status may develop any type of reflectance confocal microscopy
melanoma.
Meaning Specific phenotypic features of high-risk patients were
associated with some types of melanomas on confocal microscopy
classification.
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On the basis of the presence of major or minor criteria of
malignancy, the lesion was classified according to the
Pellacani and Barcelona confocal microscopy total score.14,15
According to thePellacani score, thecutoff formalignancywas
a score equal to or greater than 3. According to the Barcelona
algorithm, the cutoff for malignancy was a score equal to or
greater than −1.
Genetic Study
Thestudyonly includedpatients forwhomCDKN2AandMC1R
sequencing results were available. DNA samples were ob-
tained from peripheral blood lymphocytes of all patients by
standard methods, and molecular analysis was conducted at
the Molecular Genetics Department of the Hospital Clinic,
Barcelona, Spain. Specificmutations inCDKN2Aandpolymor-
phisms in MC1R were studied as previously described.16-20
MC1R polymorphisms were classified as red hair variants or
non–redhairvariants.Variants thatproducenochange inamino
acid sequence (synonymous changes)were consideredaswild
type for statistical analysis.
Statistical Analysis
Continuousvariableswereanalyzedandreportedasmean (SD)
andmedian (interquartile range). The analysis of the associa-
tion between categorical variables and outcomes used the
Pearsonχ2 test. TheFisher exact testwas appliedwhen theex-
pected frequency in the2×2 table is below5and the t testwas
used in the comparisonof quantitative variables. A κvalue for
the evaluationof the interobserver reproducibilitywas calcu-
lated for the percentage of concordant ratings. Interobserver
reproducibilitywascalculatedbasedonthe independentevalu-
ationof 2masked readers (T.C.G., I.A.)who analyzeddermos-
copy and confocal images of 10 preselected cases. The differ-
ences are considered significant at P < .05. The calculations
were made using Haploview (Broad Institute of MIT and
Harvard) andSPSS statistical software, version 16.0 (SPSS Inc).
Results
Fifty-sevenmelanomas from50patients (28women[56%]and
49 white patients [98%]) were included in the study. The me-
dian (SD) age of the participants was 53.0 (16.9) years (inter-
quartile range, 41.8-71.2 years), and themedian (SD) age at the
firstmelanomawas 46.0 (17.1) years (interquartile range, 35.8-
61.5 years). Themost prevalent histologic subtype was super-
ficial spreadingmelanoma (43of 53 [81%]), followedby lentigo
malignamelanoma (6 of 53 [11%]), nodular melanoma (3 of 53
[6%]), and nevoid melanoma (1 of 53 [2%]). According to the
American Joint Committee on Cancer classification, 31 lesions
(54%)were insitumelanomas,23 (40%)werestage I, and3 (5%)
were stage II. Fortypatients (80%)hadmultiple primarymela-
noma, and the 10 individuals (20%) with a single melanoma
weremembersof familieswithhereditarycancersyndrome.Ten
patients (20%) were CDKN2Amutation carriers.
Themean (SD)Breslow thicknesswas0.79 (0.75)mm,and
themedianthicknesswas0.52mm.Themean(SD)generalTDS
was 6.2 (0.7), the mean (SD) Barcelona general RCM score
was 1.0 (1.0), and the mean (SD) Pellacani general RCM score
was 5.0 (1.7).Melanomas arising in patientswithmultiple pri-
mary melanoma had a significantly lower mean (SD) TDS
than single melanomas developed in a familial context (6.0
[0.6] vs 7.0 [0.4], P < .001).
The classification of melanomas according to morpho-
logic subtypesvia confocal analysis resulted in23dendritic cell
types (40%), 21 round cell types (37%), 2 dermal nest types
(4%), 2 combined types (4%), and9nonclassifiable types (16%)
(Table 1 and Figure 1). The description of the data of the 3 less
Table 1. Description of Tumor Characteristics and Genetic Findings
According to Reflectance Confocal Microscopy Patterna
Tumor Feature Dendritic Cell Round Cell Dermal Nest Combined Nonclassifiable
Location
Trunk 10/23 (43.5) 13/21 (61.9) 0/2 (0) 1/2 (50.0) 7/9 (77.8)
Extremity 7/23 (41.2) 7/21 (33.3) 1/2 (50.0) 1/2 (50.0) 1/9 (11.1)
Acral 1/23 (4.3) 1/21 (4.8) 0/2 (0) 0/2 (0) 1/9 (11.1)
Facial 5/23 (21.7)b 0/21 (0) 1/2 (50.0) 0/2 (0) 0/9 (0)
Tumor size, mm
<5 6/23 (26.1) 4/21 (19.0) 1/2 (50.0) 1/2 (50.0) 3/9 (33.3)
5-10 13/23 (56.5) 13/21 (61.9) 0/2 (0) 1/2 (50.0) 5/9 (55.6)
>10 4/23 (17.4) 4/21 (19.0) 1/2 (50.0) 0/2 (0) 1/9 (11.1)
Tumor thickness,
mean (SD), mm
0.5 (0.1) 0.6 (0.5) 2.0 (1.3)b 2.1 (1.2)b 0.3 (0.2)b
Subtype
SSM 18/23 (78.3) 15/17 (88.2) 0/2 (0) 1/2 (50.0) 9/9 (100)
NM 0/23 (0) 1/17 (5.9) 1/2 (50.0) 1/2 (50.0) 0/9 (0)
LM 5/23 (21.7)b 1/17 (5.9) 0/2 (0) 0/2 (0) 0/9 (0)
Nevoid melanoma 0/23 (0) 0/17 (0) 1/2 (50.0) 0/2 (0) 0/9 (0)
CDKN2A mutation 5/23 (21.7) 3/21 (14.3) 1/2 (50.0) 2/2 (100) 2/9 (22.2)
Any MC1R variant 16/23 (69.6) 16/20 (80.0) 1/2 (50.0) 2/2 (100) 8/9 (88.9)
RHC variantc 5/23 (21.7) 7/20 (35.0) 0/2 (0) 2/2 (100) 4/9 (44.4)
ABCD TDS, mean (SD) 6.3 (0.8) 6.4 (0.6) 6.3 (0.6) 6.1 (0.7) 5.6 (0.5)b
Abbreviations: LM, lentigomaligna;
NM, nodular melanoma; RHC, red
hair variant; SSM, superficial
spreadingmelanoma; TDS, Total
Dermoscopy Score.
a Data are presented as number/total
number (percentage) of patients
unless otherwise indicated.
bP < .05 compared with other types.
c The RHC variants in patients are
R151C, R160W, D294H, and I155T.
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representative types (dermal nest, combined, and nonclassi-
fiable) is given in Table 1 and eTable 2 in the Supplement.
The interobserver κ index wasmoderate to very good for
single confocal features included in RCM melanoma scores,
ranging from 0.458 to 1.000 (eTable 1 in the Supplement).
Description ofMelanomas by RCMPattern
Individualswithdendritic cellmelanomawere ameanof 10.5
yearsolder thanpatientswith roundcellmelanoma(60.4 [17.5]
years vs 49.9 [15.6] years, P = .04). Patientswere older at first
melanomadiagnosis in thedendritic cell groupcomparedwith
the round cell group (53.6 [17.5] years vs 43.8 [14.8] years,
P = .053). All patients with dendritic cell melanoma had pho-
totype 2 or 3 disease. Compared with round cell type, pa-
tientshadamore intensehistoryofsolarexposureafter 18years
of age (10 of 23 [44%] vs 2 of 20 [10%], P = .02) andmoderate
toseveresolar lentigines (7of 18 [39%]vs 1of 15 [7%],P = .046).
Of the patients with dendritic cell melanoma, 14 of 22 (64%)
had fewer than 100nevi, and 15 of 23 (65%)hadno family his-
tory of melanoma or pancreatic cancer. The frequency of
CDKN2Amutations in this groupwas5of23 (22%), andat least
1MC1Rvariantallelewaspresent in16of23patients (70%) (with
or without the red hair phenotype). The comparative epide-
miologic and clinical data between the 2most prevalent types
ofmelanomaonRCM,dendritic and roundcell types, aregiven
in Table 2.
Dendritic cell melanomas were located mainly on the
trunk (10 of 23 [44%]) and extremities (7 of 23 [41%]).
Although not the most frequent location, the dendritic cell
type was the most prevalent confocal type in facial lesions
(5 of 6 lesions [83%]). Most of the dendritic cell melanomas
were between 5 and 10 mm. The most common histologic
subtype found in dendritic cell tumors was superficial
spreading melanoma (18 of 23 [78%]). However, the confo-
cal pattern of dendritic cell melanoma was significantly
associated with the lentigo maligna histologic subtype com-
pared with other RCM types (5 of 6 [83]% vs 1 of 6[17%],
P = .03). The mean (SD) tumor thickness in the dendritic cell
type was 0.5 (0.1) mm. More than half (13 of 23 [57%]) of
dendritic cell lesions were in situ melanomas. Regarding
dermoscopic features, dendritic cell melanomas had an
atypical pigmented network (18 of 23 [78%]) and atypical
dots and globules (22 of 23 [96%]) (Figure 2). A multicom-
ponent pattern was seen in 5 of 23 lesions (22%). The mean
(SD) TDS of the dendritic cell type was 6.3 (0.8), which was
not statistically different from the general score (mean [SD],
6.1 [0.6]; P = .58). The Barcelona confocal score achieved a
mean (SD) value of 1.0 (1.0), and the mean (SD) Pellacani
score was 4.9 (1.7).
With confocal microscopy, dendritic cell melanomas fre-
quently exhibited pagetoid cells larger than 20 μm (23 of 23
[100%] vs 21 of 34 [62%], P = .001) and pleomorphic cellular
populations (20 of 23 [87%] vs 16 of 34 [47%], P = .002). Den-
dritic cell melanomas also presented a smaller nucleus of less
than 10 μm (19 of 23 [83%] vs 11 of 34 [32%], P < .001) and a
Figure 1. Reflectance Confocal MicroscopyMorphologic Presentation According to Confocal Microscopy Classification
Dendritic cell typeA Round cell typeB Dermal nest typeC Combined typeD Nonclassifiable typeE
A,Reflectance confocalmicroscopy reveals dendritic cellswith largeprojections
andnucleuswithin upper epidermis layers seenas anatypical cobblestonepattern;
B, small roundnucleated cellswith refractive cytoplasmanddarknucleus in an
atypical honeycombepidermal pattern; C, large cerebriformnests formedby con-
fluent aggregates of low reflecting cells, brainlike in appearance;D, pleomorphic
cellular populationwithdendritic and roundcellswithin adisarrangedepidermis;
andE, dermoepidermal junctionwith ringedpattern, edgedandnonedgedpapillae
with irregular junctional nests, andmild cytologic atypia in thebasal layer.
Table 2. Association Between Reflectance Confocal Microscopy
Dendritic Cell and Round Cell Melanoma Types
and Clinical and Epidemiologic Findingsa
Variable Dendritic Cell Round Cell P Value
Female 12/23 (52.2) 15/21 (71.4) .19
Age, mean (SD), y 60.4 (17.5) 49.9 (15.6) .04b
Age at first CM,
mean (SD), y
53.6 (17.5) 43.8 (14.8) .053
Multiple CMs 19/23 (82.6) 16/21 (76.2) .72
Familial CMs 8/23 (34.8) 13/21 (61.9) .07
Phototype
1 0/23 (0) 5/21 (23.8) .02b
2 13/23 (56.5) 9/21 (42.9) .36
3 10/23 (43.5) 6/21 (28.6) .30
4 0/23 (0) 0/21 (0) NA
5 0/23 (0) 1/21 (4.8) .48
Nevus count >100 8/22 (36.4) 8/16 (50.0) .40
Solar exposure, y
<10 9/23 (39.1) 10/21 (47.6) .57
10-18 11/23 (47.8) 7/21 (33.3) .33
>18 10/23 (43.5) 2/20 (10.0) .02b
Solar lentigo,
moderate to severe
7/18 (38.9) 1/15 (6.7) .046b
Abbreviations: CM, cutaneous melanoma; NA, not applicable.
a Data are presented as number/total number (percentage) of patients unless
otherwise indicated.
bP < .05 (Pearson χ2, Fisher exact, and t tests).
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central ringed patternmore often than the other types (7 of 23
[30%] vs 3 of 34 [9%], P = .04) (eTable 2 in the Supplement).
Round cellmelanomaswere identifiedmore often in a fa-
milial context (13 of 21 [61.9%]) than dendritic cell melano-
mas (8 of 23 [34.8%], P = .07). Phototype 1 was more preva-
lent than in the dendritic cell type (5 of 21 [24%] vs 0 of 23,
P = .02), and8of 16patients (50%) in this grouphadmore than
100 nevi (Table 2). The most common location of round cell
melanomaswas on the trunk (13 of 21 [62%]).Most round cell
melanomas (13 of 21 [62%]) were between 5 and 10 mm in
diameter andwereof the superficial spreadinghistologic sub-
type (15 of 17 [88%]) (Table 1). Most round cell melanomas (13
of 21 [62%]) were in situ, and the mean (SD) tumor thickness
was0.6 (0.5)mm(Figure3).Only3 roundcellmelanomas (14%)
occurred in aCDKN2Amutation carrier. The frequency of any
MC1Rvariant allele in thismelanoma typewas80%.Themost
prevalentdermoscopic findings in roundcellmelanomaswere
atypical pigmentnetwork (17of21 [81%]) andatypicaldots and
globules (21 of 21 [100%]) (Figure 2). The global dermoscopic
pattern was classified as multicomponent in 5 of 21 lesions
(24%). The TDS presented amean (SD) value of 6.4 (0.6). The
mean (SD) RCM Barcelona score of 1.4 (0.7) was statistically
higher than other groups (mean [SD], 0.7 [1.1]; P = .006). The
mean (SD) round cell Pellacani score was 5.4 (1.1). Single con-
focal features, such as junctional thickening, dense dermal
nests, andnucleated cellswithin papillary dermis,weremore
frequently found in round cell melanomas (17 of 21 [81%] vs
16 of 36 [44%],P = .007; 8 of 21 [38%] vs 4of 36 [11%],P = .02;
and 14 of 21 [67%] vs 13 of 36 [36%], P = .03, respectively)
(eTable2 in the Supplement).
No significant association was found between the pres-
ence of CDKN2A mutations and a specific confocal mela-
noma typebeing anyRCMmelanoma typepresent inCDKN2A
carriers. The presence of at least 1 MC1R variant was associ-
atedwithwidespreadpagetoidcellswithin theepidermis com-
paredwithwild-type status (12 of 42 [29%]vs0of 14,P = .03).
Figure 2. Clinical and Dermoscopic Presentation According to Confocal Microscopy Classification
Dendritic cell typeA Round cell typeB Dermal nest typeC Combined typeD Nonclassifiable typeE
A (top), Dermoscopy reveals a melanocytic macular lesion on the left lateral
trunk; A (bottom), reticular global pattern with atypical pigment network;
B (top) melanoma on the right arm; B (bottom) globular pattern with irregular
dots and globules and focal atypical network; C (top) slightly erythematous
papular lesion on the frontal region; C (bottom) unspecific pattern with sparse
atypical globules and vessels; D (top) palpable tumor on the infraescapular
region; D (bottom)multicomponent pattern with atypical globules, blue whitish
veil, blue regression, and short white streaks; E (top) flat melanocytic lesion on
the forearm; and E (bottom) reticular pattern with atypical pigment network,
structureless areas, and segmental streaks.
Figure 3. Histopathologic Presentation According to Confocal Microscopy Classification
Dendritic cell typeA Round cell typeB Dermal nest typeC Combined typeD Nonclassifiable typeE
A, Histopathologic presentation of an in situ superficial spreadingmelanoma;
B, an in situ nevus-associated superficial spreadingmelanoma; C, a 1.1-mm-thick
nevoid melanoma; D, an ulcerated 3.0-mm-thick superficial spreading
melanoma; and E, a 0.2-mm-thick superficial spreadingmelanomawith more
than 50% regression. Hematoxylin-eosin, original magnification ×100 (A),
×100 (B), ×40 (C), ×40 (D), and ×100 (E).
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Discussion
In the present study performed on multiple primary and fa-
milial melanomas, we stratifiedmelanomas into the 5 confo-
cal typespreviouslydescribed; itwaspossible toassociate spe-
cific phenotypic features with some types of melanomas.
Dendritic cellmelanomasappeared inolderpatientswithahis-
tory of amore intense solar exposure andmoderate to severe
solar lentiginesaspreviouslydescribedbyBassoli et al.4Round
cellmelanomashadapredisposition for fair-skinned individu-
als and tended to occur with a family history of melanoma.
However, in this study, theassociationwithahighnevuscount
or thepresenceof atypical neviwasnot observed in the round
cell melanoma type, as previously reported.11
Dendritic cell and round cell melanomas were not differ-
ent regarding tumor thicknessor tumorsize,differing fromthat
previously described.11 These findings reinforce the hypoth-
esis that at least 2 different routes of melanoma development
exist. The first was associated with multiple nevi, predomi-
nanceon the trunk, andyoungerageatonset, characterizedvia
RCMbyroundcellpattern.Thesecondwasassociatedwithlong-
termsundamageandolderageatonset, characterizedviaRCM
asadendritic cell type.A thirdpossible, less frequent routemay
exist, characterized by thick and fast-growing tumors with a
nested pattern via confocal microscopy. More advanced
lesionshadamulticomponentpattern,probablyreflectinglesion
evolutionwith 1of the3previouspatterns.Finally, lesionswith
unspecificpatternareprobablyveryearlymelanomas inwhich
the pattern is as yet undefined.21
MeanBarcelona scorewashigher in roundcell type, prob-
ably because of the higher frequency of atypical nucleated
dermal cells. These findings support the behavior of round
cell melanomas to aggregate into clusters at the dermal-
epidermal junction andpapillary dermis and also to spread as
isolated cells into the dermis. The dendritic cell melanomas,
adjusting for tumors of similar stage and thickness, may take
a longer time for single cells to aggregate into nests and to
disseminate into the dermis, possibly representing slow-
growing melanomas as previously proposed.11
ConsideringTDS,RCMscore,andtumorthickness, it ispos-
sible that the combined and nonclassifiable melanomas rep-
resentoppositeendsofamorphologic spectrum. In fact,milder
morphologic expression in dermoscopy and confocal exami-
nation of nonclassifiable type is characteristic of early-stage
tumors, which are frequently difficult to diagnose by in vivo
techniques.
CDKN2Amutation carriersmay develop any RCM type of
melanoma, even those less represented as dermal nests. It is
possible that the low sample size was not able to demon-
strate any differences in the distribution between different
types, if they actually exist.
Conclusions
Specific phenotypic features of patientswithmultipleprimary
and familial melanomas were associated with some types of
melanomas based on confocal microscopy classification.
Morphologic expressionofmelanomasunderdermoscopyand
confocal examinationmaybeassociatedwithdifferences in tu-
mor stage and biological behavior. Future studies are neces-
sary to enhance our knowledge of the interaction of multiple
coexisting causal factors that drivemelanoma development.
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NOTABLENOTES
History of Podophyllin
Ismaël Maatouk, MD
Podophyllotoxin is theprincipal active compound fromthe resinmixture
known as podophyllin. It is obtained from 1 of the 3 species of Podophyl-
lum:Ppeltatum (fromNorthAmerica),Phexandrum (fromIndia;previously
referredtoasPemodi),orPpleianthum (fromTaiwan).1Podophyllumpelta-
tum is an indigenous,NorthAmerican,herbaceousperennial flowering in
Mayandbearingfruit in latesummeror fall.Othercommonnames include
May apple,mandrake, Indian apple,wild lemon, andduck's foot.1
Oneof the first recordedmedicinal uses of this agent,mentioned in
thepre-ConquestEnglishmedical book theLeechBookofBald (AD900-
950), was in a salve for cancer.1-3Catesby, in his Natural History of the
Carolinas (1731), described theMayappleandnoted that the root is “said
to be an excellent emetic and is used as such in the Carolinas.” Jacques
Cartier reportedusageof this agentbothasamortalpoisonandasa topi-
cal antidote for snake venom.1-3 The root was considered both a medi-
cine and a poison by the North American Indians, and it was used as a
suicide agent among the Iroquois.1,3 John Uri Lloyd stated that Podo-
phyllumwas used by the Cherokees for deafness and as an anthelmin-
tic, and by theWyandottes and Southern Indians as a cathartic.1
Theearly colonists learnedof themedicalpropertiesof the root from
the Indians, and itwas used as a cathartic in the firstUnited States Phar-
macopoeia (1820).1-3 It was listed until the 12th revision (1942), from
which it was dropped. Stories of the new American drug spread to En-
gland and the continent of Europe.1-3The resin, podophyllin, was first
separated from Podophyllumby JohnKing in 1835.1-3With the prepara-
tion of podophyllin on a commercial scale in 1850 byMerrell the use of
the resin supplanted thatof thecrudePodophyllum.1 Between 1863 (4th
revision of the United States Pharmacopoeia) and 1942 (12th revision),
podophyllinwas reported tobeacathartic, purgative, deobstruent, ver-
mifuge,hydragogue,cholagogue,choleretic, andexpectorant. Itwas rec-
ommended, either alone or in combination with other herbs, for dis-
easesof the liverandkidneys, forscrofula, syphilis,gonorrhea,obstructed
menstruation, urinary obstruction, dropsy, and coughs.1-3
With the increased production of podophyllin, reports of its toxic
properties appeared in the literature: pain in theeyes; hyperemiaof the
iris, cornea,mucousmembranes, and eyelids; and erythematous erup-
tions of the scrotum. Moreover, oral and parenteral administration of
podophyllin has been followed by serious results. Topical podophyllin
was introduced in 1942 and is still accepted today as an effective treat-
ment for condyloma acuminatum.3
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